Click Product Name to review monograph.
DISCLAIMER: Printed versions of any document may not be the most current version. Although every effort to ensure that all information is accurate and complete, documents and policies are regularly under review and in the process of being amended and blood product information/inserts may change. The most current version of the policy, and/or product insert/circular of information shall apply. Users should verify that any policy is the most current policy before acting on it. Contact your facility paging for the Transfusion Medicine Hematopathologist on call if required.
Document Number |
Product Name |
Effective Date |
160-65-01 | 29OCT20 20 | |
160-65-02 | 20MAY2021 | |
160-65-03 | 04NOV2019 | |
160-65-04 | 04NOV2019 | |
160-65-05 | 04NOV2019 | |
160-65-06 | 15JULY2021 | |
160-65-07 |
15MAR2018 | |
160-65-08 | 28 NOV 2019 | |
160-65-09 | 28NOV2019 | |
160-65-10 | 28NOV2019 | |
160-65-12 |
24OCT2019 | |
160-65-13 |
24OCT2019 | |
160-65-14 |
24OCT2019 | |
160-65-15 |
FVIII/vWF Humate P Antihemophilic Factor/vonWillbrand Factor Complex |
24OCT2019 |
160-65-16 |
24OCT2019 | |
160-65-17 |
24OCT2019 | |
160-65-18 |
24OCT2019 | |
160-65-19 |
24OCT2019 | |
160-65-20 | 03DEC20 20 | |
160-65-21 | 06MAY2021 | |
160-65-22 | 21NOV2019 | |
160-65-25 | 28NOV2019 | |
160-65-26 |
24OCT2019 | |
160-65-27 |
24OCT2019 | |
160-65-28 |
24OCT2019 | |
160-65-29 | Tetanus B Immune Globulin | 28NOV2019
|
160-65-30 |
24OCT2019 | |
160-65-31 160-65-32160-65-33 | Obizur Antihemophilic Factor, Recombinant Porcine Sequence HemlibraJIVI, AntihemophilicFactor (recombinent, B-domain deleted, PEGylated) | 24OCT2019 28NOV201906AUG2020 |
160-65-35 | Fibryga (Fibrinogen Concentrate) | 19NOV2020 |
160-65-36 | Haegarda (C1 Esterase Inhibitor Subcutaneous) | 22JUL2021 |